ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 558 filers reported holding ASTRAZENECA PLC in Q3 2019. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $225,803 | -1.2% | 3,155 | -4.2% | 0.02% | +4.2% |
| Q1 2023 | $228,637 | -55.4% | 3,294 | -57.6% | 0.02% | -54.7% |
| Q2 2022 | $513,000 | +1.2% | 7,768 | +1.7% | 0.05% | +15.2% |
| Q1 2022 | $507,000 | +23.4% | 7,636 | +8.3% | 0.05% | +48.4% |
| Q4 2021 | $411,000 | -7.4% | 7,051 | -4.7% | 0.03% | -13.9% |
| Q3 2021 | $444,000 | +14.7% | 7,401 | +14.6% | 0.04% | +12.5% |
| Q2 2021 | $387,000 | +20.6% | 6,460 | 0.0% | 0.03% | +10.3% |
| Q1 2021 | $321,000 | -39.4% | 6,460 | -39.1% | 0.03% | -44.2% |
| Q4 2020 | $530,000 | -51.0% | 10,605 | -46.3% | 0.05% | -56.7% |
| Q3 2020 | $1,081,000 | +236.8% | 19,734 | +225.2% | 0.12% | +215.8% |
| Q2 2020 | $321,000 | +11.8% | 6,069 | -5.5% | 0.04% | -5.0% |
| Q1 2020 | $287,000 | -65.9% | 6,422 | -71.8% | 0.04% | -9.1% |
| Q4 2019 | $842,000 | +155.9% | 22,760 | +207.9% | 0.04% | -2.2% |
| Q3 2019 | $329,000 | – | 7,391 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |